Extreme βHCG levels in first trimester screening are risk factors for adverse maternal and fetal outcomes
- PMID: 36681713
- PMCID: PMC9867730
- DOI: 10.1038/s41598-023-28561-9
Extreme βHCG levels in first trimester screening are risk factors for adverse maternal and fetal outcomes
Abstract
Multiples of the normal median (MoM) of free βHCG is a valuable parameter in evaluation of risk of adverse pregnancy outcomes. In the current retrospective study, we assessed the maternal and fetal outcomes in pregnant women having free βHCG MoM levels < 0.2 or > 5 in their first trimester screening (FTS). Relative risk of trisomy 21 was significantly higher in patients having free βHCG MoM > 5. On the other hand, relative risk of trisomies 13 and 18 and Turner syndrome were higher in those having free βHCG MoM < 0.2. Other chromosomal abnormalities were nearly equally detected between those having free βHCG MoM < 0.2 or > 5. Relative risk of hydrocephaly and hydrops fetalis was higher when free βHCG MoM was below 0.2. On the other hand, relative risk of low birth weight was higher when free βHCG MoM was above 5. Moreover, frequency of gestational diabetes mellitus, preeclampsia, preterm delivery and vaginal bleeding increased with levels of free βHCG MoM. However, polyhydramnios had the opposite trend. Frequencies of premature rupture of membranes and pregnancy induced hypertension were highest among pregnant women having levels of free βHCG MoM < 0.2. The current study indicates importance of free βHCG MoM in identification of at-risk pregnancies in terms of both fetal and maternal outcomes. In fact, βHCG MoM < 0.2 or > 5 can be regarded as risk factors for adverse maternal or fetal outcomes irrespective of the presence of other abnormalities in the FTS results.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Assessment of β-human-derived chorionic gonadotrophic hormone (βhCG) and pregnancy-associated plasma protein A (PAPP-A) levels as predictive factors of preeclampsia in the first trimester among Iranian women: a cohort study.BMC Pregnancy Childbirth. 2019 Dec 4;19(1):464. doi: 10.1186/s12884-019-2526-x. BMC Pregnancy Childbirth. 2019. PMID: 31801467 Free PMC article.
-
Comparison of triple-risk assessment of fetal trisomy 21 including total human choriogonadotropin (hCG) or its free beta-subunit (free beta hCG).Fetal Diagn Ther. 2003 Mar-Apr;18(2):122-7. doi: 10.1159/000068073. Fetal Diagn Ther. 2003. PMID: 12576748
-
Obstetrical complications associated with abnormal maternal serum markers analytes.J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5. J Obstet Gynaecol Can. 2008. PMID: 19038077 Review. English, French.
-
Eliminating first trimester markers: will replacing PAPP-A and βhCG miss women at risk for small for gestational age?J Matern Fetal Neonatal Med. 2014 Nov;27(17):1761-4. doi: 10.3109/14767058.2013.879703. Epub 2014 Feb 10. J Matern Fetal Neonatal Med. 2014. PMID: 24460472
-
First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.Ultrasound Obstet Gynecol. 2006 Oct;28(5):637-43. doi: 10.1002/uog.3809. Ultrasound Obstet Gynecol. 2006. PMID: 16952214 Review.
Cited by
-
First Trimester Placental Biomarkers for Pregnancy Outcomes.Int J Mol Sci. 2024 Jun 2;25(11):6136. doi: 10.3390/ijms25116136. Int J Mol Sci. 2024. PMID: 38892323 Free PMC article. Review.
-
Recent advances and new perspectives in mitochondrial dysfunction.Sci Rep. 2023 May 17;13(1):7977. doi: 10.1038/s41598-023-34624-8. Sci Rep. 2023. PMID: 37198256 Free PMC article.
-
Evaluation of the relationships between beta-human chorionic gonadotropin (β-hCG) blood levels and pregnancy: A retrospective study.Pak J Med Sci. 2025 Jul;41(7):1955-1961. doi: 10.12669/pjms.41.7.12250. Pak J Med Sci. 2025. PMID: 40735583 Free PMC article.
-
Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.BMC Womens Health. 2024 Jun 4;24(1):323. doi: 10.1186/s12905-024-03105-z. BMC Womens Health. 2024. PMID: 38835013 Free PMC article.
-
The Efficacy of Multiwavelength Red and Near-Infrared Transdermal Photobiomodulation Light Therapy in Enhancing Female Fertility Outcomes and Improving Reproductive Health: A Prospective Case Series with 9-Month Follow-Up.J Clin Med. 2024 Nov 24;13(23):7101. doi: 10.3390/jcm13237101. J Clin Med. 2024. PMID: 39685560 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources